1. Chang H, Salma F, Yi Q, Patterson B, Brien B, Minden MD. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leuk Res. 2004;28:43–8.
2. McCulloch EA, Kellecher CA, Miauchi J, Wang C, Cheng GYN, et al. Heterogeneity in acute myeloblastic leukemia. Leukemia. 1988;2(Suppl 12):36s–49s.
3. Raspadori D, Damiani D, Lenoci M, Rondeli D, Testoni N, et al. CD56 antigen expression in acute myeloid leukemia identifies patients with poor prognosis. Leukemia. 2001;15:1161–4.
4. Ciolli S, Leoni F, Nozzoli C, Longo G, Gianfaldoni G, et al. Prognostic impact of CD56 in 141 cases of acute myeloid leukemia. Haematologica. 2001;86(Suppl 10): a17 (abstract).
5. Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodighiero F. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica. 2002;87:250–6.